Skip to main content
Log in

Early detection of P-VEP and PERG changes in opthalmic Graves' disease

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

• Background: In Graves' disease the optic neuropathy (ON) is due to direct compression of the nerve and/or of its blood supply. The aim of the present study was to detect early changes in the visual functions of patients affected by ophthalmic Graves' disease (OGD) by using electrophysiological tests (P-VEP and PERG). • Methods: We studied 50 OGD patients who were in a range between class 2 and class 5 according to the Donaldson-American Thyroid Association classification, i.e. had no evident ON and normal visual acuity. We recorded transient reversal PERG and P-VEP in response to the stimulation of one eye at three spatial frequencies (2.2, 1.1 and 0.5 c/d). • Results: Our results showed a statistically significant reduction in PERG amplitude in class 5, while the P-VEP amplitude was already reduced in class 2. • Conclusion: The electrofunctional tests were useful to detect small changes in the visual function of patients affected by initial stages of OGD. Therefore, P-VEP and PERG recordings appear to be a useful tool for early diagnosis of the optic nerve involvement in Graves' disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adachi-Usami E (1990) Senescence of visual function as studied by visually evoked cortical potentials. Jpn J Ophthalmol 34:81–94

    Google Scholar 

  2. Bobak P, Friedman R, Brigell M, Goodwin J, Anderson R (1988) Visual evoked potentials to multiple temporal frequencies. Arch Ophthalmol 106:936–940

    Google Scholar 

  3. Burke W, Cottee LJ, Garvey J, Kumarasinghe R, Kriacou C (1986) Selective degeneration of optic nerve fibres in the cat produced by a pressure block. J Physiol 376:461–476

    Google Scholar 

  4. Coleman DJ, Dallow RL (1978) Ophthalmic ultrasonography, ocular ultrasonography, orbital ultrasonography. In: Duane FD (ed). Harper&Row, pp 25–27

  5. Dallow RL, Momose KJ, Weber AL (1976) Comparison of ultrasonography, computerized tomography (EMI scan) and radiographic techniques in evaluation of exophthalmos. Trans Am Acad Ophthalmol Otolaryngol 81:305–322

    Google Scholar 

  6. Donaldson SS, Bagshaw MA, Kriss JP (1973) Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 37: 276–285

    Google Scholar 

  7. Esser J, Sobczynski H (1988) Therapiebegleitende Verlaufsbeobachtung der visuell evozierten kortikalen Potentiale bei Patienten mit endokriner Ophthalmopathie (Stadium 6). Fortschr Ophthalmol 85: 541–544

    Google Scholar 

  8. Gorman CA, Bahn RS (1989) Pathogenesis of Graves' ophthalmopathy. Dev Ophthalmol 20:1–7

    Google Scholar 

  9. Gorman CA, Waller RR, Dyer JA (1984) The eye and orbit in thyroid disease. Raven Press, New York

    Google Scholar 

  10. Holder GE, Condon JR (1989) Pattern visual evoked potentials and pattern electroretinograms in hypothyroidism. Doc Ophthalmol 73:127–131

    Google Scholar 

  11. Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC (1984) Immunchistochemical and ultrastructural studies on the exenterated orbital tissue of a patient with Graves' disease. Ophthalmology 91:1411–1419

    Google Scholar 

  12. Kennerdell IS, Rosenbaum AE, El Hoshy MH (1981) Apical optic nerve compression of dysthyroid optic neuropathy on computed tomography. Arch Ophthalmol 99:807–809

    Google Scholar 

  13. Ladenson PW, Stakes JW, Ridgway EC (1984) Reversible alteration of the visual evoked potential in hypothyroidism. Am J Med 77:1010–3

    Google Scholar 

  14. Leone CR, Bajandas FJ (1981) Inferior orbital decompression for dysthyroid optic neuropathy. Ophthalmology 88:525–532

    Google Scholar 

  15. Maffei L, Fiorentini A (1981) Electroretinographic responses to alternating gratings before and after section of the optic nerve. Science 211: 953–955

    Google Scholar 

  16. Mastaglia FL, Black JL, Collins DWK, Gutteridge DH, Yeun RWM (1978) Slowing of conduction in visual pathway in hypothyroidism. Lancet i:387

    Google Scholar 

  17. Mitchell KW, Wood CM, Howe JW (1988) Pattern visual evoked potentials in hypothyroidism. Br J Ophthalmol 72:534–537

    Google Scholar 

  18. Neigel JM, Rottman J, Belkin RI (1988) Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology 95:1515–1521

    Google Scholar 

  19. Pearlman JT, Burian HM (1964) Electroretinographic findings in thyroid dysfunction. Am J Ophthalmol 58:216–226

    Google Scholar 

  20. Spadea L, D'Amico M, Dragani T, Balestrazzi E (1994) Esami elettrofunzionali. Sintomi funzionali senza evidenze papillari. Proc. XV Corso APIMO 11 nervo ottico nella pratica clinica. Arbe, Modena, pp 63–72

  21. Takahashi K, Fujitani Y (1970) Somatosensory and visual evoked potentials in hyperthyroidism. Electroencephalogr Clin Neurophysiol 29: 551–556

    Google Scholar 

  22. Trobe JD (1981) Optic nerve involvement in dysthyroidism. Ophthalmology 88:488–492

    Google Scholar 

  23. Van Ouerkerk BM, Wijngaarde R (1985) Radiotherapy of severe ophthalmic Graves' disease. J Endocrinol Invest 8: 241–247

    Google Scholar 

  24. Wijngaarde R, Van Lith GHM (1979) Pattern EPS in endocrine orbitopathy. Doc Ophthalmol 48: 327–332

    Google Scholar 

  25. Wirth A (1968) ERG and endocrine disorders. In: Francois J (ed) The clinical value of electroretinography. ISCERG Symposium, Ghent, 1966. Karger, Basel, pp 260–266

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spadea, L., Bianco, G., Dragani, T. et al. Early detection of P-VEP and PERG changes in opthalmic Graves' disease. Graefe's Arch Clin Exp Ophthalmol 235, 501–505 (1997). https://doi.org/10.1007/BF00947007

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00947007

Keywords

Navigation